Literature DB >> 22675156

Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Christina T Fiske1, Alexandre S de Almeida, Ayumi K Shintani, Spyros A Kalams, Timothy R Sterling.   

Abstract

Persons with previous extrapulmonary tuberculosis have reduced peripheral blood mononuclear cell cytokine production and CD4(+) lymphocytes compared to persons with previous pulmonary tuberculosis or latent tuberculosis infection, but specific defects related to Mycobacterium tuberculosis infection of macrophages have not been characterized. The objective of this study was to further characterize the in vitro immune responses to M. tuberculosis infection in HIV-seronegative persons with previous extrapulmonary tuberculosis. Peripheral blood mononuclear cells were isolated from HIV-seronegative persons with previous extrapulmonary tuberculosis (n = 11), previous pulmonary tuberculosis (n = 21), latent M. tuberculosis infection (n = 19), and uninfected tuberculosis contacts (n = 20). Experimental conditions included M. tuberculosis-infected macrophages cultured with and without monocyte-depleted peripheral blood mononuclear cells. Concentrations of interleukin 1β (IL-1β), IL-4, IL-6, CXCL8 (IL-8), IL-10, IL-12p70, IL-17, CCL2 (monocyte chemoattractant protein 1), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) were measured by multiplex cytokine array. When M. tuberculosis-infected macrophages were cocultured with monocyte-depleted peripheral blood mononuclear cells, IFN-γ (P = 0.01), TNF-α (P = 0.04), IL-10 (P < 0.001), and IL-6 (P = 0.03) exhibited similar continua of responses, with uninfected persons producing the lowest levels, followed by extrapulmonary tuberculosis cases, pulmonary tuberculosis controls, and persons with latent M. tuberculosis infection. A similar pattern was observed with CXCL8 (P = 0.04), IL-10 (P = 0.02), and CCL2 (P = 0.03) when monocyte-depleted peripheral blood mononuclear cells from the four groups were cultured alone. Persons with previous extrapulmonary tuberculosis had decreased production of several cytokines, both at rest and after stimulation with M. tuberculosis. Our results suggest that persons who develop extrapulmonary tuberculosis have a subtle global immune defect that affects their response to M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22675156      PMCID: PMC3416084          DOI: 10.1128/CVI.00221-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis.

Authors:  V Hari Sai Priya; B Anuradha; Suman Latha Gaddam; Seyed E Hasnain; K J R Murthy; Vijaya Lakshmi Valluri
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

3.  Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.

Authors:  C S Hirsch; Z Toossi; C Othieno; J L Johnson; S K Schwander; S Robertson; R S Wallis; K Edmonds; A Okwera; R Mugerwa; P Peters; J J Ellner
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

4.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 5.  Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities.

Authors:  D A Lewinsohn; M L Gennaro; L Scholvinck; D M Lewinsohn
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

Review 6.  Tuberculous pleural effusion.

Authors:  José M Porcel
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

7.  Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.

Authors:  Bushra Jamil; Firdaus Shahid; Zahra Hasan; Nosheen Nasir; Tashmeem Razzaki; Ghaffar Dawood; Rabia Hussain
Journal:  Tuberculosis (Edinb)       Date:  2007-05-29       Impact factor: 3.131

8.  Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.

Authors:  Timothy R Sterling; Terezinha Martire; Alexandre Silva de Almeida; Li Ding; David E Greenberg; Lorena Alves Moreira; Houda Elloumi; Angelica P V Torres; Clemax Couto Sant'Anna; Eliane Calazans; Geraldo Paraguassu; Tebeb Gebretsadik; Ayumi Shintani; Kathleen Miller; Afranio Kritski; Jose Roberto Lapa e Silva; Steven M Holland
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

Review 9.  Dynamics of cytokine generation in patients with active pulmonary tuberculosis.

Authors:  Eun-Kyeong Jo; Jeong-Kyu Park; Hazel M Dockrell
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

10.  Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.

Authors:  Zahra Hasan; Irfan Zaidi; Bushra Jamil; M Aslam Khan; Akbar Kanji; Rabia Hussain
Journal:  BMC Immunol       Date:  2005-07-07       Impact factor: 3.615

View more
  7 in total

1.  Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.

Authors:  Caian L Vinhaes; Deivide Oliveira-de-Souza; Paulo S Silveira-Mattos; Betania Nogueira; Ruiru Shi; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Clifton E Barry; Laura E Via; Kiyoshi F Fukutani; Bruno B Andrade; Katrin D Mayer-Barber
Journal:  Cytokine       Date:  2019-06-18       Impact factor: 3.861

2.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

3.  Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area.

Authors:  Hye Won Kim; Jin Kyun Park; Ji-Ae Yang; Young Im Yoon; Eun Young Lee; Yeong Wook Song; Hang Rae Kim; Eun Bong Lee
Journal:  Clin Rheumatol       Date:  2013-09-22       Impact factor: 2.980

4.  25-Hydroxyvitamin D levels after recovery from tuberculosis: insights into pathogenesis.

Authors:  Moises A Huaman; Timothy R Sterling; Bryan E Shepherd; Christina T Fiske
Journal:  Tuberculosis (Edinb)       Date:  2013-11-06       Impact factor: 3.131

5.  Cytokine Biomarkers Associated with Human Extra-Pulmonary Tuberculosis Clinical Strains and Symptoms.

Authors:  Paulo Ranaivomanana; Mihaja Raberahona; Sedera Rabarioelina; Ysé Borella; Alice Machado; Mamy J De Dieu Randria; Rivo A Rakotoarivelo; Voahangy Rasolofo; Niaina Rakotosamimanana
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

6.  Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosis.

Authors:  Christina T Fiske; Amondrea Blackman; Fernanda Maruri; Peter F Rebeiro; Moises Huaman; Jamie Kator; Holly M Scott Algood; Timothy R Sterling
Journal:  BMC Infect Dis       Date:  2019-04-30       Impact factor: 3.090

7.  Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals.

Authors:  Nathan Shaviya; Valentine Budambula; Mark K Webale; Tom Were
Journal:  Interdiscip Perspect Infect Dis       Date:  2016-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.